Katherine Gorcyca

Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany

Winfried März, Franz‐Werner Dippel, Karlheinz Theobald et al. · Atherosclerosis · 2017 · 89 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Low-density lipoprotein cholesterol levels and lipid-modifying therapy prescription patterns in the real world: An analysis of more than 33,000 high cardiovascular risk patients in Japan

Tamio Teramoto, Kiyoko Uno, Izuru Miyoshi et al. · Atherosclerosis · 2016 · 71 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Patterns and predictors of lipid‐lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large <scp>US</scp> managed‐care population

Dylan Steen, Irfan Khan, Laura Becker et al. · Clinical Cardiology · 2016 · 45 citations · Full text

Medicine, Cardiology, Pharmacotherapy +12

Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice

Marcello Arca, David Ansell, Maurizio Averna et al. · Atherosclerosis · 2018 · 39 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice

Jean Ferrières, Katherine Gorcyca, Şerban R. Iorga et al. · Clinical Therapeutics · 2018 · 12 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +11